From a clinical perspective, clarifying the role of GAS6 signaling from bench to clinic will provide great benefit in development of strategies for the prevention and treatment of obesity and its related complications. The gene discussed is GAS6; the disease is obesity due to melanocortin 4 receptor deficiency.